ZAMBROTTA, GIOVANNI PAOLO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 464
EU - Europa 257
AS - Asia 46
SA - Sud America 2
AF - Africa 1
Totale 770
Nazione #
US - Stati Uniti d'America 463
IT - Italia 85
DE - Germania 75
IE - Irlanda 45
SE - Svezia 23
CN - Cina 21
GB - Regno Unito 10
HK - Hong Kong 10
IN - India 4
SG - Singapore 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
TR - Turchia 3
AT - Austria 2
FI - Finlandia 2
FR - Francia 2
JP - Giappone 2
RU - Federazione Russa 2
UA - Ucraina 2
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
CO - Colombia 1
IR - Iran 1
MU - Mauritius 1
NO - Norvegia 1
RO - Romania 1
VN - Vietnam 1
Totale 770
Città #
Ann Arbor 228
Frankfurt am Main 57
Dublin 44
Milan 43
Chandler 29
Wilmington 27
Ashburn 26
Fairfield 24
Houston 16
New York 16
Hong Kong 10
Cambridge 9
Seattle 9
Princeton 8
Altamura 7
Lodi 7
Woodbridge 7
Beijing 5
Dearborn 5
Guangzhou 5
Lawrence 4
Washington 4
Ankara 3
Brno 3
Bonndorf 2
Cruseilles 2
Fremont 2
Grafing 2
Helsinki 2
Jamaica Plain 2
Munich 2
Nichelino 2
Nova Milanese 2
Sapporo 2
Shanghai 2
Shenyang 2
Vienna 2
Acton 1
Andover 1
Boardman 1
Bogotá 1
Bologna 1
Carate Brianza 1
Cardano al Campo 1
Chaoyang 1
Cinisello Balsamo 1
Dallas 1
Edmonton 1
Esslingen am Neckar 1
Falls Church 1
Hanoi 1
Jacksonville 1
Kilburn 1
Nanchang 1
Nanjing 1
Novokuznetsk 1
Oxford 1
Padova 1
Phoenix 1
Redmond 1
Rome 1
Sacramento 1
San Mateo 1
Segrate 1
Stockholm 1
Taizhou 1
Tianjin 1
Trumbull 1
Vijayawada 1
Zhengzhou 1
Totale 655
Nome #
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 259
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 229
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 214
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study 59
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 34
ETNK1 mutations increase mitochondrial activity and promote DNA damage through ROS production 21
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape 12
Totale 828
Categoria #
all - tutte 2.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 2 4 4
2019/202065 5 4 11 2 3 6 12 4 5 8 5 0
2020/2021262 1 3 9 7 9 9 85 43 27 20 28 21
2021/2022152 22 20 18 17 18 10 0 4 5 5 14 19
2022/2023175 19 46 18 10 18 21 3 11 12 0 11 6
2023/2024154 3 6 7 19 27 40 28 6 13 5 0 0
Totale 828